Louisiana State Employees Retirement System Innoviva, Inc. Transaction History

Louisiana State Employees Retirement System

$5.54 Billion
Q4 2025

A detailed history of Louisiana State Employees Retirement System transactions in Innoviva, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 32,500 shares of INVA stock, worth $723,125. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,500

Previous 27,500 18.18%

Holding current value

$723,125

Previous $501,000 44.31%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 16, 2026	BUY	$16.67 - $22.28 $83,350 - $111,400	5,000 Added 18.18%	32,500 $723,000
Q3 2025 Oct 22, 2025	BUY	$18.17 - $20.92 $30,889 - $35,564	1,700 Added 6.59%	27,500 $501,000
Q2 2025 Jul 23, 2025	SELL	$17.1 - $21.8 $1,710 - $2,180	-100 Reduced 0.39%	25,800 $518,000
Q1 2025 May 01, 2025	SELL	$17.21 - $18.98 $12,047 - $13,286	-700 Reduced 2.63%	25,900 $469,000
Q3 2024 Oct 23, 2024	SELL	$16.33 - $20.04 $16,329 - $20,040	-1,000 Reduced 3.62%	26,600 $513,000

Q2 2024 Jul 24, 2024	SELL	$14.4 - $16.4 $4,320 - $4,920	-300 Reduced 1.08%	27,600 $452,000
Q1 2024 Apr 23, 2024	SELL	$14.56 - $16.78 $4,368 - $5,034	-300 Reduced 1.06%	27,900 $425,000
Q4 2023 Jan 29, 2024	SELL	$12.32 - $16.27 $12,320 - $16,270	-1,000 Reduced 3.42%	28,200 $452,000
Q3 2023 Oct 17, 2023	SELL	$12.37 - $13.89 $21,029 - $23,613	-1,700 Reduced 5.5%	29,200 $379,000
Q2 2023 Jul 18, 2023	BUY	$11.39 - $13.72 $18,224 - $21,952	1,600 Added 5.46%	30,900 $393,000
Q1 2023 Apr 19, 2023	SELL	$10.73 - $13.6 $5,365 - $6,800	-500 Reduced 1.68%	29,300 $329,000
Q4 2022 Jan 24, 2023	SELL	$11.8 - $13.78 $2,360 - $2,756	-200 Reduced 0.67%	29,800 $395,000
Q3 2022 Oct 19, 2022	SELL	$11.61 - $15.22 $3,483 - $4,566	-300 Reduced 0.99%	30,000 $348,000
Q2 2022 Jul 20, 2022	SELL	$14.32 - $19.88 $1,432 - $1,988	-100 Reduced 0.33%	30,300 $446,000
Q1 2022 Apr 22, 2022	BUY	$15.39 - $20.25 $1,539 - $2,025	100 Added 0.33%	30,400 $556,000
Q4 2021 Jan 14, 2022	BUY	$15.91 - $18.72 $3,182 - $3,744	200 Added 0.66%	30,300 $523,000
Q3 2021 Oct 12, 2021	BUY	$13.06 - $17.24 $22,202 - $29,307	1,700 Added 5.99%	30,100 $503,000
Q2 2021 Jul 16, 2021	SELL	$11.45 - $13.96 $2,290 - $2,792	-200 Reduced 0.7%	28,400 $381,000
Q1 2021 Apr 14, 2021	SELL	$11.06 - $12.87 $3,318 - $3,860	-300 Reduced 1.04%	28,600 $342,000
Q4 2020 Jan 11, 2021	SELL	$9.33 - $12.48 $1,866 - $2,496	-200 Reduced 0.69%	28,900 $358,000
Q3 2020 Oct 19, 2020	BUY	$10.33 - $14.49 $112,906 - $158,375	10,930 Added 60.15%	29,100 $304,000
Q2 2020 Jul 13, 2020	SELL	$11.49 - $15.26 $3,447 - $4,578	-300 Reduced 1.62%	18,170 $254,000
Q1 2020 Apr 13, 2020	SELL	$8.11 - $15.23 $35,927 - $67,468	-4,430 Reduced 19.34%	18,470 $217,000
Q4 2019 Jan 17, 2020	SELL	$10.28 - $14.38 $18,504 - $25,884	-1,800 Reduced 7.29%	22,900 $324,000
Q3 2019 Oct 24, 2019	SELL	$10.05 - $14.55 $6,030 - $8,730	-600 Reduced 2.37%	24,700 $260,000
Q1 2019 Apr 15, 2019	SELL	$13.69 - $20.06 $930 - $1,364	-68 Reduced 0.27%	25,300 $355,000
Q4 2018 Jan 14, 2019	SELL	$13.96 - $18.26 $64,662 - $84,580	-4,632 Reduced 15.44%	25,368 $443,000
Q3 2018 Oct 16, 2018	SELL	$13.63 - $15.7 $12,267 - $14,130	-900 Reduced 2.91%	30,000 $457,000
Q2 2018 Jul 18, 2018	BUY	$13.44 - $17.59 $2,688 - $3,518	200 Added 0.65%	30,900 $426,000
Q1 2018 Apr 18, 2018	SELL	$13.8 - $16.99 $12,420 - $15,290	-900 Reduced 2.85%	30,700 $512,000
Q4 2017 Jan 16, 2018	BUY	$11.73 - $14.75 $17,595 - $22,125	1,500 Added 4.98%	31,600 $448,000
Q3 2017 Oct 16, 2017	BUY	$12.06 - $14.12 $363,006 - $425,012	30,100	30,100 $425,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

83.5M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Innoviva, Inc. Transaction History